Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Grant to reduce number of chickens used in research
The grant will fund the development of laboratory techniques for studying poultry viral diseases, without the need to infect live birds.
Pirbright research could have a ‘worldwide impact’ 

A Pirbright scientist has secured a grant to reduce the number of chickens used in research.

Dr Andrew Broadbent received more than £300,000 from the National Centre for the Replacement Refinement and Reduction of Animals in Research (NC3Rs).

The grant will fund the development of laboratory techniques for studying poultry viral diseases, without the need to infect live birds.

“We need improved methods for controlling these viruses and in order to realise that goal we need better tools to study them,” said Dr Broadbent, an Institute Fellow at the Pirbright Institute.

“Traditionally, research in this field has used a lot of infected birds; we hope that we can replace their use with our primary B cell model to improve our understanding of virus-cell interactions and test the ability of vaccines to produce an immune response.

“Not only would this help improve current control methods, it would reduce the number of birds required for research.”

Dr Broadbent’s research will focus on three important poultry infections: infectious bursal disease virus, avian leukosis virus, and reticuloendotheliosis virus.

Up to now, studying how these viruses interact with the cells they infect has been difficult to achieve in the laboratory. This is because the B cells die when they they are removed from the chickens, meaning that researchers have no choice but to use live infected birds in their studies.

Researchers at Pirbright, however, have found a way to extend the life of chicken B cells in the lab.

NC3Rs grant aims to test whether these cells can be used as a model to study virus infection and produce reliable results comparable to experiments conducted in live chickens.

Scientists also hope to learn whether the cells can replace chickens needed to produce virus stocks, and determine if they can be used to screen vaccine candidates. A team at Imperial College London will then build on this work by analysing how the cells respond genetically to infection using RNA sequencing.

The Pirbright Institute says the research could have a ‘worldwide impact' on the study of avian immunosuppressive viruses.

‘If scientists researching these viruses around the world were to adopt the new laboratory methods, it is estimated that over 5,000 fewer chickens would be required for experimental studies each year,’ it said in a press release. ‘Furthermore, if these viruses are better controlled as a result of this work, the overall welfare of birds would be improved.’

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.